Clin2
NCT07510958Possibly a fitNot yet recruiting

Testing an Inhaled Drug for Safety in Healthy Adults

Healthy Participants

This study tests an inhaled medication called SYH2059 to see how safe it is and how the body processes it. It is for healthy adults and involves taking the drug once or multiple times to measure its effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
84 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You must be between 18 and 55 years old.
  • You must weigh at least 110 pounds (women) or 110 pounds (men) and have a BMI between 19 and 28.
  • You must not have a history of lung diseases like asthma or COPD, or significant allergies.
  • You must not smoke 5 or more cigarettes per day.
  • You must be willing to use effective non-hormonal birth control or have permanent contraception for 6 months after the study ends.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07771777Not yet recruiting· Phase 1
Safety study of an experimental drug in healthy adults

This trial tests a new investigational drug called SYH2056 in healthy volunteers to see if it is safe and how the body handles it. It also checks how food affects the drug. Participating may help determine if the drug can be developed for future patients.

NCT07412353Recruiting· Phase 1
Testing safety of single dose SYH2085 in healthy people

This study tests a single dose of an investigational drug called SYH2085 in healthy volunteers to check for side effects, how the body processes the drug, and what happens at different doses. If you qualify, you will help doctors understand if the drug is safe before testing it in patients.

Shanghai, Shanghai Municipality
NCT07647783Recruiting· Phase 1
Safety Study of SYH2072 Tablet in Healthy Adults

This is an early-stage safety study testing a new experimental tablet called SYH2072 in healthy volunteers. Researchers will give increasing doses to understand how safe it is, how your body processes it, and what effects it has.

Beijing, Beijing Municipality
NCT07301203Recruiting· Phase 1
Healthy volunteer study of inhaled CPD704

This early-phase study tests a new inhaled medication called CPD704 in healthy volunteers. It checks safety and how the body processes the drug.

Beijing, Beijing Municipality
NCT07241910Recruiting· Phase 1
Testing the safety of SYH2061 in healthy volunteers

This study tests a single dose of a new medication called SYH2061 to see if it is safe and how the body processes it. It is for healthy adults aged 18 to 55 who have had certain vaccines and are willing to follow study rules.

Hefei, Anhui
NCT07719218Not yet recruiting· Phase 1
Safety study of inhaled drug ICF004 in healthy volunteers

This trial tests a new inhaled medication called ICF004 in healthy Chinese adults to see if it is safe and how the body processes it. You can join if you are generally healthy and between 18 and 50 years old.

Hear when a new Healthy Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.